MICHEAL KITZMILLER: Open Payments
NPI 1629714720 · MIAMISBURG, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 30 payments from 9 companies in 2025. Trend: 2023 $285 · 2024 $277 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $232 |
| Vanda Pharmaceuticals Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Vertical Pharmaceuticals, LLC | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, Jornay PM, Auvelity, Relexxii, FANAPT, HETLIOZ, SPRAVATO.
Industry payments across OH — which companies pay providers there.
